Thromb Haemost 1990; 64(02): 335
DOI: 10.1055/s-0038-1647313
Original Article
Schattauer GmbH Stuttgart

Von Willebrand Factor (vWF) - Why Are the Largest Multimers Most Efficient in Hemostasis?

Helge Stormorken
The Research Institute for Internal Medicine Rikshospitalet 0027 Oslo 1 Norway
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 06. März 1990

Accepted 31. Mai 1990

Publikationsdatum:
25. Juli 2018 (online)

 
  • References

  • 1 Smiley RK, Tittley P, Rock G. Studies on the prolonged bleeding time in von Willebrand’s disease. Thromb Res 1989; 53: 417-426
  • 2 Sixma JJ. Platelet adhesion in health and disease. In: Thrombosis and Haemostasis 1987 Verstraete M, Vermylen J, Lijnen R, Amout J. (eds) Leuven University Press; 1987. pp 127-146
  • 3 Carino T, Goldsmith HL. Rheological factors in thrombosis and haemostasis. In: Hemostasis and Thrombosis. Bloom AL, Thomas DP. (eds) Churchill-Livingstone; London: 1987. pp 739-755
  • 4 Duke WW. The relation of blood platelets to hemorrhagic disease. Discussion of a method for determining bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. J Am Med Assoc 1910; 55: 1185-1197
  • 5 Hellem AJ, Borchgrevink CF, Ames SB. The role of red cells in hemostasis: The relation between hematocrit, bleeding time and platelet adhesiveness. Br J Haematol 1961; 7: 42-50
  • 6 Gaarder A, Jonsen J, Laland S, Hellem A, Owren PA. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961; II 531-532
  • 7 Fowler WE, Fretto LJ, Hamilton KK, Erickson HP, McKee PA. Substructure of human von Willebrand factor. J Clin Invest 1985; 76: 1491-1500
  • 8 Carlsson LA, Bottiger LE. Risk factors for ischaemic heart disease in men and women. Results of the 19-year follow-up of the Stockholm Prospective Study. Acta Med Scand 1985; 218: 207-211